FDA — authorised 23 May 2002
- Application: ANDA065010
- Marketing authorisation holder: X GEN PHARMS
- Local brand name: NEO-FRADIN
- Indication: SOLUTION — ORAL
- Status: approved
FDA authorised Neomycin Oral Product on 23 May 2002
Yes. FDA authorised it on 23 May 2002.
X GEN PHARMS holds the US marketing authorisation.